U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Delpire-McNeill syndrome

Summary

Delpire-McNeill syndrome (DELMNES) is a neurodevelopmental disorder with highly variable manifestations. Patients present in infancy with global developmental delay, including motor, speech, and impaired intellectual development. The most severely affected patients have hypotonia, inability to hold their head or walk, bilateral sensorineural deafness, and absent language, whereas others have delayed walking and mild to moderate intellectual disability, often with speech delay and autistic features. More variable features may include spasticity or minor involvement of other organ systems, such as hip dislocation or ventricular septal defect (summary by McNeill et al., 2020). [from OMIM]

Available tests

4 tests are in the database for this condition.

Genes See tests for all associated and related genes

  • Also known as: BSC, BSC-2, BSC2, CCC1, KILQS, NKCC1, PPP1R141, hNKCC1, SLC12A2
    Summary: solute carrier family 12 member 2

Clinical features

Help

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.